Latest Articles
Advanced Fellowship in Minimally Invasive Gynecological Surgery (AF MIGS) - VA.gov Home | Veterans Affairs
Advanced Fellowship in Minimally Invasive Gynecological Surgery (AF MIGS) VA.gov Home | Veterans Affairs
Published: Aug. 26, 2025, 9:45 p.m.
Top Reasons to Buy AXOL(axol) - Trade Entry Summary & Weekly Setup with ROI Potential - Newser
Top Reasons to Buy AXOL(axol) - Trade Entry Summary & Weekly Setup with ROI Potential Newser
Published: Aug. 26, 2025, 8:36 p.m.
Is this a good reentry point in Eagle Point Income Company Inc. - July 2025 Earnings & Long Hold Capital Preservation Tips - Newser
Is this a good reentry point in Eagle Point Income Company Inc. - July 2025 Earnings & Long Hold Capital Preservation Tips Newser
Published: Aug. 26, 2025, 8:31 p.m.
Savannah Chrisley makes surprising confession about Botox plans - Geo.tv
Savannah Chrisley makes surprising confession about Botox plans Geo.tv
Published: Aug. 26, 2025, 8:27 p.m.
Neuroscience Leader Neurocrine Biosciences Sets Extensive Conference Schedule with Key Executives Presenting - Stock Titan
Neuroscience Leader Neurocrine Biosciences Sets Extensive Conference Schedule with Key Executives Presenting Stock Titan
Published: Aug. 26, 2025, 8:01 p.m.
The Utah Endometriosis Center at St. Mark’s Hospital is open now to serve patients - FOX 13 News Utah
The Utah Endometriosis Center at St. Mark’s Hospital is open now to serve patients FOX 13 News Utah
Published: Aug. 26, 2025, 7:43 p.m.
Genmab's Rina-S: A Game-Changer in Endometrial Cancer and a Catalyst for Shareholder Value - AInvest
Genmab's Rina-S: A Game-Changer in Endometrial Cancer and a Catalyst for Shareholder Value AInvest
Published: Aug. 26, 2025, 7:31 p.m.
FDA Breakthrough Therapy Granted for Novel ADC in Endometrial Cancer - Targeted Oncology
FDA Breakthrough Therapy Granted for Novel ADC in Endometrial Cancer Targeted Oncology
Published: Aug. 26, 2025, 6:30 p.m.
Rina-S Given Breakthrough Therapy Designation in Endometrial Cancer - Oncology Nursing News
Rina-S Given Breakthrough Therapy Designation in Endometrial Cancer Oncology Nursing News
Published: Aug. 26, 2025, 6:04 p.m.
Genmab's Rina-S: A Breakthrough in Endometrial Cancer and a Catalyst for Shareholder Value - AInvest
Genmab's Rina-S: A Breakthrough in Endometrial Cancer and a Catalyst for Shareholder Value AInvest
Published: Aug. 26, 2025, 5:39 p.m.
Link copied to clipboard!